Wachtell Steers Abbott In $25B Deal For St. Jude Medical
Abbott Laboratories, led by Wachtell, unveiled on Thursday a $25 billion cash-and-stock acquisition of medical device maker St. Jude Medical, strengthening its position in the cardiovascular market with products that can...To view the full article, register now.
Already a subscriber? Click here to view full article